Chemokine 'grooming' by cLECs directs DC migration

Nature Immunology

Volumn 15, Issue 7, 2014, Pages 595-596

  Woodruff, Matthew C ^a,b   Turley, Shannon J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCRL1; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG; INTERCELLULAR ADHESION MOLECULE 1;

ANTIGEN PRESENTATION; CELL MIGRATION; DENDRITIC CELL; IMMUNE RESPONSE; LEUKOCYTE MIGRATION; LYMPH VESSEL ENDOTHELIUM; LYMPHOCYTE; LYMPHOCYTE MIGRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; STROMA CELL; T LYMPHOCYTE; TIGHT JUNCTION; ENDOTHELIUM CELL; LYMPH NODE; LYMPHATIC ENDOTHELIAL CELL;

ANIMALS; CHEMOKINE CCL21; LYMPH NODES; RECEPTORS, CCR;

EID: 84902653643     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2926     Document Type: Short Survey

References (14)

1. Ulvmar, M.H. et al. Nat. Immunol. 15, 623-630 (2014).
2. von Andrian, U. H. & Mempel, T. R. Nat. Rev. Immunol. 3, 867-878 (2003).
3. Ohl, L. et al. Immunity 21, 279-288 (2004).
4. Acton, S.E. et al. Immunity 37, 276-289 (2012).
5. Braun, A. et al. Nat. Immunol. 12, 879-887 (2011).
6. Phan, T.G., Grigorova, I., Okada, T. & Cyster, J.G. Nat. Immunol. 8, 992-1000 (2007).
7. Moseman, E.A. et al. Immunity 36, 415-426 (2012).
8. Ito, K. et al. Proc. Natl. Acad. Sci. USA 111, 3080-3085 (2014).
9. Cohen, J.N. et al. J. Exp. Med. 207, 681-688 (2010).
10. Stein, J.V. et al. J. Exp. Med. 191, 61-76 (2000).
11. Groom, J.R. et al. Immunity 37, 1091-1103 (2012).
12. Fletcher, A.L. et al. J. Exp. Med. 207, 689-697 (2010).
13. Baekkevold, E.S. et al. J. Exp. Med. 193, 1105-1112 (2001).
14. Liu, H. et al. Nature 507, 519-522 (2014).